[{"address1": "451 D Street", "address2": "5th Floor Suite 501", "city": "Boston", "state": "MA", "zip": "02210", "country": "United States", "phone": "857 209 0050", "website": "https://elicio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Elicio Therapeutics, Inc., a clinical-stage biotechnology company, develops a pipeline of novel immunotherapies for the treatment of cancer. Its lead product candidate is ELI-002, a multivalent lymph node\u0096targeted AMP peptide vaccine that is in Phase II clinical trial to target seven Kirsten rat sarcoma viral oncogene homolog driver mutations. The company is also developing ELI-007, a multivalent lymph node\u0096targeted AMP peptide vaccine to target mutant v-raf murine sarcoma viral oncogene homolog B1 gene mutations found in solid tumors; and ELI-008, a multivalent lymph node\u0096targeted AMP peptide vaccine to target p53 hotspot mutations. The company is headquartered in Boston, Massachusetts.", "fullTimeEmployees": 32, "companyOfficers": [{"maxAge": 1, "name": "Mr. Robert T. Connelly", "age": 64, "title": "CEO, President, Principal Accounting Officer, Principal Financial Officer & Director", "yearBorn": 1960, "fiscalYear": 2023, "totalPay": 678300, "exercisedValue": 0, "unexercisedValue": 239308}, {"maxAge": 1, "name": "Dr. Allen Richard Nissenson F.A.S.N., FACP, M.D.", "age": 77, "title": "Founder & Independent Director", "yearBorn": 1947, "fiscalYear": 2023, "totalPay": 52520, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Christopher M. Haqq M.D., Ph.D.", "age": 58, "title": "Executive VP, Head of Research & Development and Chief Medical Officer", "yearBorn": 1966, "fiscalYear": 2023, "totalPay": 673821, "exercisedValue": 0, "unexercisedValue": 161616}, {"maxAge": 1, "name": "Dr. Darrell J. Irvine Ph.D.", "title": "Co-Founder, Consultant, Board Observer & Chairman of Scientific Advisory Board", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Michael  DiVecchia", "title": "Senior Vice President of Operations & Human Resources", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Peter  DeMuth Ph.D.", "age": 38, "title": "Chief Scientific Officer", "yearBorn": 1986, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Megan C. Filoon", "title": "General Counsel, Secretary & Compliance Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Esther  Welkowsky", "title": "Senior Vice President of Clinical Development", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Joy  Seymour", "title": "VP & Head of Regulatory Affairs", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Thian  Kheoh Ph.D.", "title": "Senior Vice President of Biometrics", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 7, "compensationRisk": 8, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1740787200, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 7.97, "open": 8.05, "dayLow": 7.735, "dayHigh": 8.1671, "regularMarketPreviousClose": 7.97, "regularMarketOpen": 8.05, "regularMarketDayLow": 7.735, "regularMarketDayHigh": 8.1671, "payoutRatio": 0.0, "forwardPE": -3.0330741, "volume": 31906, "regularMarketVolume": 31906, "averageVolume": 42674, "averageVolume10days": 32490, "averageDailyVolume10Day": 32490, "bid": 0.0, "ask": 7.85, "bidSize": 0, "askSize": 1, "marketCap": 123643512, "fiftyTwoWeekLow": 3.342, "fiftyTwoWeekHigh": 11.45, "fiftyDayAverage": 7.7696, "twoHundredDayAverage": 5.74093, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 85925664, "profitMargins": 0.0, "floatShares": 6771970, "sharesOutstanding": 15861900, "sharesShort": 161508, "sharesShortPriorMonth": 145788, "sharesShortPreviousMonthDate": 1738281600, "dateShortInterest": 1740700800, "sharesPercentSharesOut": 0.0134000005, "heldPercentInsiders": 0.43861, "heldPercentInstitutions": 0.07157, "shortRatio": 2.83, "shortPercentOfFloat": 0.0161, "impliedSharesOutstanding": 15861900, "bookValue": -1.761, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -46843000, "trailingEps": -3.44, "forwardEps": -2.57, "lastSplitFactor": "1:10", "lastSplitDate": 1685664000, "enterpriseToEbitda": -2.117, "52WeekChange": 0.2075758, "SandP52WeekChange": 0.07465422, "quoteType": "EQUITY", "currentPrice": 7.795, "targetHighPrice": 12.0, "targetLowPrice": 12.0, "targetMeanPrice": 12.0, "targetMedianPrice": 12.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 1, "totalCash": 26016000, "totalCashPerShare": 2.414, "ebitda": -40586000, "totalDebt": 26050000, "quickRatio": 2.884, "currentRatio": 3.398, "returnOnAssets": -0.73697, "freeCashflow": -25206124, "operatingCashflow": -38219000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "ELTX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Elicio Therapeutics, Inc.", "longName": "Elicio Therapeutics, Inc.", "corporateActions": [], "regularMarketTime": 1742413402, "exchange": "NCM", "messageBoardId": "finmb_214936128", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "REGULAR", "regularMarketChangePercent": -2.1957304, "regularMarketPrice": 7.795, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1612535400000, "regularMarketChange": -0.17499971, "regularMarketDayRange": "7.735 - 8.1671", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 42674, "fiftyTwoWeekLowChange": 4.453, "fiftyTwoWeekLowChangePercent": 1.3324357, "fiftyTwoWeekRange": "3.342 - 11.45", "fiftyTwoWeekHighChange": -3.6549997, "fiftyTwoWeekHighChangePercent": -0.31921396, "fiftyTwoWeekChangePercent": 20.75758, "earningsTimestampStart": 1743078600, "earningsTimestampEnd": 1743424200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -3.44, "epsForward": -2.57, "epsCurrentYear": -4.065, "priceEpsCurrentYear": -1.9175892, "fiftyDayAverageChange": 0.025400162, "fiftyDayAverageChangePercent": 0.0032691725, "twoHundredDayAverageChange": 2.05407, "twoHundredDayAverageChangePercent": 0.35779393, "priceToBook": -4.426462, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Angion Biomedica Corp.", "nameChangeDate": "2025-03-15", "averageAnalystRating": "2.0 - Buy", "cryptoTradeable": false, "displayName": "Elicio Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-03-19"}]